Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xin'an Guben Peiyuan Shugan Jianpi Fang
- Development stage
- Unknown
- Lead developer
- First Affiliated Hospital of Anhui University of Chinese Medicine
- Administration
- Oral
01
Overview
Xin'an Guben Peiyuan Shugan Jianpi Fang is a Traditional Chinese Medicine (TCM) herbal formula developed by the First Affiliated Hospital of Anhui University of Chinese Medicine, rooted in the regional Xin'an medical tradition. The formula is designed according to the therapeutic principles of 'strengthening the foundation' (Guben Peiyuan), 'soothing the liver' (Shugan), and 'fortifying the spleen' (Jianpi). It is primarily utilized as an adjuvant therapy for patients with advanced gastric cancer, particularly those undergoing chemotherapy regimens such as SOX (S-1 and Oxaliplatin). Clinical research indicates that the formula helps to mitigate chemotherapy-induced toxicity, improve immune function by modulating T-lymphocyte subsets, and enhance the overall quality of life and clinical response rates in cancer patients.
- Other names
- 新安固本培元疏肝健脾方Xin'an Guben Peiyuan Shugan Jianpi Formula
02
Targets
IL-2 (Interleukin 2)VEGFA (Vascular endothelial growth factor A)
Beyond the preview
Go deeper on Xin'an Guben Peiyuan Shugan Jianpi Fang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xin'an Guben Peiyuan Shugan Jianpi Fang.